Evidence-Based Updates & Advocacy
In a significant observational study conducted in Sweden, researchers have uncovered a potentially life-saving benefit of attention-deficit/hyperactivity disorder (ADHD) medication. The study, involving 148,578 individuals… Continue Reading ADHD Medication Could Be a Lifesaver, New Study Suggests
In the realm of Attention-Deficit/Hyperactivity Disorder (ADHD) treatments, four promising pipeline agents are currently under late-stage development across the seven major markets (7MM), including the… Continue Reading New ADHD Treatments Herald Comorbid Anxiety & Depression
Published on 31/01/2024 in Cureus The case study paper explores the association between autism spectrum disorder (ASD) and common mental health disorders, focusing on the… Continue Reading Stimulant Use in ADHD with ASD and Psychosis: A Case Study
Published on 10/07/2023 in CNS Drugs (Springer) The study was conducted retrospectively with data obtained for clinical purposes and received no specific grant from funding… Continue Reading Viloxazine More Effective Than Atomoxetine
Published in BJPsych Open(Cambridge) on 22/01/2024 Suicide and the association of mental illness, particularly attention-deficit hyperactivity disorder (ADHD), with increased risk of suicide attempts and… Continue Reading ADHD Stimulant Treatment Cuts Suicide Risk!
On November 23, 2023, Lancet Psychiatry published a meta-analysis delving into the critical issue of ADHD medication discontinuation and persistence across diverse age groups and… Continue Reading ADHD Medication Discontinuation: An In-depth Analysis